Infliximab is a drug used to treat autoimmune disorders. Infliximab is known as a "chimeric monoclonal antibody" . The drug blocks the action of TNF by binding to it and preventing it from signaling the receptors for TNF on the surface of cells. TNF is one of the key cytokines that triggers and sustains the inflammation response. Remicade was developed by Junming Le and Jan Vilcek at New York University...